1. A safety and feasibility study with platelet lysate expanded bone marrow mesenchymal stromal cells for the treatment of acute graft-versus-host disease in Brazil. Issue 5 (May 2014) Authors: Silla, Lucia; Valim, Vanessa; Amorin, Bruna; Alegretti, Ana Paula; dos Santos de Oliveira, Fernanda; Lima da Silva, Maria Aparecida; Dahmer, Alice; Emerim Lemos, Natália; Mentz Albrecht, Márcia Arthmar; Macedo Laureano, Álvaro; Bonfim, Carmem; Moraes Júnior, Lauro; Pezzi, Annelise; Baggio, Letíci... Journal: Leukemia & lymphoma Issue: Volume 55:Issue 5(2014:May) Page Start: 1203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial. Issue 5 (May 2021) Authors: Matasar, Matthew J; Capra, Marcelo; Özcan, Muhit; Lv, Fangfang; Li, Wei; Yañez, Eduardo; Sapunarova, Katya; Lin, Tongyu; Jin, Jie; Jurczak, Wojciech; Hamed, Aryan; Wang, Ming-Chung; Baker, Ross; Bondarenko, Igor; Zhang, Qingyuan; Feng, Jifeng; Geissler, Klaus; Lazaroiu, Mihaela; Saydam, Guray; Sz... Journal: Lancet oncology Issue: Volume 22:Issue 5(2021) Page Start: 678 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial. Issue 10292 (19th June 2021) Authors: Moreau, Philippe; Dimopoulos, Meletios-Athanasios; Mikhael, Joseph; Yong, Kwee; Capra, Marcelo; Facon, Thierry; Hajek, Roman; Špička, Ivan; Baker, Ross; Kim, Kihyun; Martinez, Gracia; Min, Chang-Ki; Pour, Ludek; Leleu, Xavier; Oriol, Albert; Koh, Youngil; Suzuki, Kenshi; Risse, Marie-Laure; Asset... Journal: Lancet Issue: Volume 397:Issue 10292(2021) Page Start: 2361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Newly diagnosed and previously treated multicentric Castleman disease respond equally to siltuximab. (31st October 2020) Authors: van Rhee, Frits; Rossi, Jean‐François; Simpson, David; Fosså, Alexander; Dispenzieri, Angela; Kuruvilla, John; Goh, Yeow Tee; Cho, Seok‐Goo; Capra, Marcelo; Liu, Ting; Casper, Corey; Cavet, James; Wong, Raymond S. Journal: British journal of haematology Issue: Volume 192:Number 1(2021) Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗